Meta-analysis of apolipoprotein e gene polymorphism and susceptibility of myocardial infarction

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Xu, Hong ^a   Li, Haiqing ^a   Liu, Jun ^a   Zhu, Dan ^a   Wang, Zhe ^a   Chen, Anqing ^a   Zhao, Qiang ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ALLELE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HEART INFARCTION; HUMAN; META ANALYSIS;

ALLELES; APOLIPOPROTEINS E; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC;

EID: 84905861857     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104608     Document Type: Article

References (54)

1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ (2006) Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367: 1747-1757. (Pubitemid 43767064)
2. Gu JY, Li LW (2014) ALDH2 Glu504Lys Polymorphism and Susceptibility to Coronary Artery Disease and Myocardial Infarction in East Asians: A Meta-analysis. Arch Med Res 45: 76-83.
3. Wang J, Xu D, Wu X, Zhou C, Wang H, et al. (2011) Polymorphisms of matrix metalloproteinases in myocardial infarction: a meta-analysis. Heart 97: 1542-1546.
4. Ozaki K, Tanaka T (2005) Genome-wide association study to identify SNPs conferring risk of myocardial infarction and their functional analyses. Cell Mol Life Sci 62: 1804-1813. (Pubitemid 41188520)
5. Szpakowicz A, Pepinski W, Waszkiewicz E, Maciorkowska D, Skawronska M, et al. (2014) Retraction: polymorphism of 9p21.3 locus is associated with 5-year survival in high-risk patients with myocardial infarction. PLoS One 9: e95513.
6. Jin Y, Wang Q, Wang G, Zhang X, Yan B, et al. (2014) Common polymorphisms in the interleukin-6 gene and myocardial infarction risk: a meta-analysis. Genet Test Mol Biomarkers 18: 330-340.
7. Wang Q, Zhou SB, Wang LJ, Lei MM, Wang Y, et al. (2014) Seven functional polymorphisms in the CETP gene and myocardial infarction risk: a meta-analysis and meta-regression. PLoS One 9: e88118.
8. Scott J, Knott TJ, Shaw DJ, Brook JD (1985) Localization of genes encoding apolipoproteins CI, CII, and E to the p13-cen region of human chromosome 19. Hum Genet 71: 144-146. (Pubitemid 16178881)
9. Stampfer MJ, Sacks FM, Salvini S, Willett WC, Hennekens CH (1991) A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction. N Engl J Med 325: 373-381.
10. Lahiri DK, Sambamurti K, Bennett DA (2004) Apolipoprotein gene and its interaction with the environmentally driven risk factors: molecular, genetic and epidemiological studies of Alzheimer's disease. Neurobiol Aging 25: 651-660. (Pubitemid 38686488)
11. Zhang R, Wang X, Tang Z, Liu J, Yang S, et al. (2014) Apolipoprotein E gene polymorphism and the risk of intracerebral hemorrhage: a meta-analysis of epidemiologic studies. Lipids Health Dis 13: 47.
12. Shin MH, Choi JS, Rhee JA, Lee YH, Nam HS, et al. (2014) APOE polymorphism and carotid atherosclerosis in Korean population: the Dong-gu Study and the Namwon Study. Atherosclerosis 232: 180-185.
13. Singh NK, Banerjee BD, Bala K, Mitrabasu, Dung Dung AA, et al. (2014) APOE and LRPAP1 gene polymorphism and risk of Parkinson's disease. Neurol Sci.
14. Zhu S, Wang Z, Wu X, Shu Y, Lu D (2014) Apolipoprotein E polymorphism is associated with lower extremity deep venous thrombosis: color-flow Doppler ultrasound evaluation. Lipids Health Dis 13: 21.
15. Takeuchi F, Isono M, Katsuya T, Yokota M, Yamamoto K, et al. (2012) Association of genetic variants influencing lipid levels with coronary artery disease in Japanese individuals. PLoS One 7: e46385.
16. Chaudhary R, Likidlilid A, Peerapatdit T, Tresukosol D, Srisuma S, et al. (2012) Apolipoprotein E gene polymorphism: effects on plasma lipids and risk of type 2 diabetes and coronary artery disease. Cardiovasc Diabetol 11: 36.
17. Atabek ME, Ozkul Y, Eklioglu BS, Kurtoglu S, Baykara M (2012) Association between apolipoprotein E polymorphism and subclinic atherosclerosis in patients with type 1 diabetes mellitus. J Clin Res Pediatr Endocrinol 4: 8-13.
18. Song Y, Stampfer MJ, Liu S (2004) Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann Intern Med 141: 137-147. (Pubitemid 38937836)
19. Yin YW, Sun QQ, Zhang BB, Hu AM, Liu HL, et al. (2013) Association between apolipoprotein E gene polymorphism and the risk of coronary artery disease in Chinese population: evidence from a meta-analysis of 40 studies. PLoS One 8: e66924.
20. Utermann G, Hardewig A, Zimmer F (1984) Apolipoprotein E phenotypes in patients with myocardial infarction. Hum Genet 65: 237-241. (Pubitemid 14182014)
21. Cumming AM, Robertson FW (1984) Polymorphism at the apoprotein-E locus in relation to risk of coronary disease. Clin Genet 25: 310-313. (Pubitemid 14157792)
22. Lenzen HJ, Assmann G, Buchwalsky R, Schulte H (1986) Association of apolipoprotein E polymorphism, low-density lipoprotein cholesterol, and coronary artery disease. Clin Chem 32: 778-781. (Pubitemid 17028348)
23. Eichner JE, Kuller LH, Orchard TJ, Grandits GA, McCallum LM, et al. (1993) Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease. Am J Cardiol 71: 160-165. (Pubitemid 23030638)
24. Luc G, Bard JM, Arveiler D, Evans A, Cambou JP, et al. (1994) Impact of apolipoprotein E polymorphism on lipoproteins and risk of myocardial infarction. The ECTIM Study. Arterioscler Thromb 14: 1412-1419.
25. Hergenc G, Taga Y, Emerk K, Cirakoglu B (1995) Apolipoprotein E Genotyping in Turkish Myocardial Infarction Survivors and Healthy Controls. J Biomed Sci 2: 46-49.
26. Kim IJ, Hong BK, Lee BK, Kwon HM, Kim D, et al. (1999) Apolipoprotein E polymorphism in non-diabetic patients with acute coronary syndrome. Yonsei Med J 40: 377-382.
27. Nakai K, Fusazaki T, Zhang T, Shiroto T, Osawa M, et al. (1998) Polymorphism of the apolipoprotein E and angiotensin I converting enzyme genes in Japanese patients with myocardial infarction. Coron Artery Dis 9: 329-334. (Pubitemid 28486696)
28. Scaglione L, Bergerone S, Gambino R, Imazio M, Macchia G, et al. (1999) Role of lipid, apolipoprotein levels and apolipoprotein E genotype in young Italian patients with myocardial infarction. Nutr Metab Cardiovasc Dis 9: 118-124. (Pubitemid 129632897)
29. Lambert JC, Brousseau T, Defosse V, Evans A, Arveiler D, et al. (2000) Independent association of an APOE gene promoter polymorphism with increased risk of myocardial infarction and decreased APOE plasma concentrations-the ECTIM study. Hum Mol Genet 9: 57-61. (Pubitemid 30145288)
30. Benes P, Muzik J, Benedik J, Frelich M, Elbl L, et al. (2000) Single effects of apolipoprotein B, (a), and E polymorphisms and interaction between plasminogen activator inhibitor-1 and apolipoprotein(a) genotypes and the risk of coronary artery disease in Czech male caucasians. Mol Genet Metab 69: 137-143. (Pubitemid 30180698)
31. Batalla A, Alvarez R, Reguero JR, Hevia S, Iglesias-Cubero G, et al. (2000) Synergistic effect between apolipoprotein E and angiotensinogen gene polymorphisms in the risk for early myocardial infarction. Clin Chem 46: 1910-1915.
32. Raslova K, Smolkova B, Vohnout B, Gasparovic J, Frohlich JJ (2001) Risk factors for atherosclerosis in survivors of myocardial infarction and their spouses: comparison to controls without personal and family history of atherosclerosis. Metabolism 50: 24-29. (Pubitemid 32058544)
33. Bai X, Zhao M, Wang B (2001) [Dyslipidemia-related risk factors for myocardial infarction and polymorphism of ApoE gene among myocardial infarction patients and their siblings]. Zhonghua Yi Xue Za Zhi 81: 340-343.
34. Freitas EM, Phan TC, Herbison CE, Christiansen FT, Taylor RR, et al. (2002) The poliovirus receptor related 2 (PRR2) and apolipoprotein E genes and coronary heart disease. J Cardiovasc Risk 9: 59-65. (Pubitemid 34311435)
35. Mamotte CD, Burke V, Taylor RR, van Bockxmeer FM (2002) Evidence of reduced coronary artery disease risk for apolipoprotein epsilon2/3 heterozygotes. Eur J Intern Med 13: 250-255. (Pubitemid 34627055)
36. Kolovou G, Yiannakouris N, Hatzivassiliou M, Malakos J, Daskalova D, et al. (2002) Association of apolipoprotein E polymorphism with myocardial infarction in Greek patients with coronary artery disease. Curr Med Res Opin 18: 118-124. (Pubitemid 34665748)
37. Keavney B, Parish S, Palmer A, Clark S, Youngman L, et al. (2003) Large-scale evidence that the cardiotoxicity of smoking is not significantly modified by the apolipoprotein E epsilon2/epsilon3/epsilon4 genotype. Lancet 361: 396-398. (Pubitemid 36164977)
38. Kolovou GD, Daskalova D, Hatzivassiliou M, Yiannakouris N, Pilatis ND, et al. (2003) The epsilon 2 and 4 alleles of apolipoprotein E and ischemic vascular events in the Greek population-implications for the interpretation of similar studies. Angiology 54: 51-58. (Pubitemid 36222542)
39. Kumar P, Luthra K, Dwivedi M, Behl VK, Pandey RM, et al. (2003) Apolipoprotein E gene polymorphisms in patients with premature myocardial infarction: a case-controlled study in Asian Indians in North India. Ann Clin Biochem 40: 382-387. (Pubitemid 36819556)
40. Marques-Vidal P, Bongard V, Ruidavets JB, Fauvel J, Perret B, et al. (2003) Effect of apolipoprotein E alleles and angiotensin-converting enzyme insertion/deletion polymorphisms on lipid and lipoprotein markers in middle-aged men and in patients with stable angina pectoris or healed myocardial infarction. Am J Cardiol 92: 1102-1105. (Pubitemid 37329537)
41. Keavney B, Palmer A, Parish S, Clark S, Youngman L, et al. (2004) Lipid-related genes and myocardial infarction in 4685 cases and 3460 controls: discrepancies between genotype, blood lipid concentrations, and coronary disease risk. Int J Epidemiol 33: 1002-1013. (Pubitemid 39429993)
42. Ranjith N, Pegoraro RJ, Rom L, Rajput MC, Naidoo DP (2004) Lp(a) and apoE polymorphisms in young South African Indians with myocardial infarction. Cardiovasc J S Afr 15: 111-117. (Pubitemid 39056138)
43. Baum L, Ng HK, Wong KS, Tomlinson B, Rainer TH, et al. (2006) Associations of apolipoprotein E exon 4 and lipoprotein lipase S447X polymorphisms with acute ischemic stroke and myocardial infarction. Clin Chem Lab Med 44: 274-281. (Pubitemid 43357684)
44. Aasvee K, Jauhiainen M, Kurvinen E, Tur I, Sundvall J, et al. (2006) Determinants of risk factors of atherosclerosis in the postinfarction period: the Tallinn MI study. Scand J Clin Lab Invest 66: 191-199. (Pubitemid 43994983)
45. Koch W, Hoppmann P, Schomig A, Kastrati A (2008) Apolipoprotein E gene epsilon2/epsilon3/epsilon4 polymorphism and myocardial infarction: case-control study in a large population sample. Int J Cardiol 125: 116-117. (Pubitemid 351305408)
46. Kolovou GD, Anagnostopoulou KK, Cokkinos DV (2009) Apolipoprotein E gene polymorphism and myocardial infarction. Int J Cardiol 133: 264-265.
47. Bahri R, Esteban E, Moral P, Hassine M, Ben Hamda K, et al. (2008) Apolipoprotein gene polymorphisms and plasma levels in healthy Tunisians and patients with coronary artery disease. Lipids Health Dis 7: 46.
48. Martinelli N, Olivieri O, Shen GQ, Trabetti E, Pizzolo F, et al. (2009) Additive effect of LRP8/APOER2 R952Q variant to APOE epsilon2/epsilon3/epsilon4 genotype in modulating apolipoprotein E concentration and the risk of myocardial infarction: a case-control study. BMC Med Genet 10: 41.
49. Al-Bustan SA, Alkhalaf M, Al-Rashdan I, Al-Otaibi S, Al-Baker E, et al. (2009) Apolipoprotein E, CI and B gene polymorphisms in a sample of patients with coronary heart disease in the Kuwaiti population. Med Princ Pract 18: 294-299.
50. Onrat ST, Akci O, Soylemez Z, Onrat E, Avsar A (2012) Prevalence of myocardial infarction polymorphisms in Afyonkarahisar, Western Turkey. Mol Biol Rep 39: 9257-9264.
51. Tanguturi P, Pullareddy B, Kumar PS, Murthy DK (2013) Association between apolipoprotein E gene polymorphism and myocardial infarction. Biochem Genet 51: 398-405.
52. Zende PD, Bankar MP, Kamble PS, Momin AA (2013) Apolipoprotein e gene polymorphism and its effect on plasma lipids in arteriosclerosis. J Clin Diagn Res 7: 2149-2152.
53. Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, et al. (2002) Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol 155: 487-495. (Pubitemid 34208040)
54. Dallongeville J, Lussier-Cacan S, Davignon J (1992) Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis. J Lipid Res 33: 447-454.